BA Trial for Co-Occurring Depression and Substance Use

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 12, 2018

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
DepressionSubstance Use Disorders
Interventions
BEHAVIORAL

Behavioural Activation

The BA intervention will be the outpatient version of the Life Enhancement Treatment for Substance Use (LETS ACT; Daughters et al., 2008). This brief, manualised BA intervention has been specifically developed to meet the needs of patients with comorbid substance misuse and depression in drugs and alcohol treatment settings. LETS ACT targets the link between mood, substance use and behaviour, and focuses on identifying and increasing rewarding, substance-free activities that are based on the patient's own personal values.

BEHAVIORAL

Treatment as Usual

The control intervention in this study is Treatment as Usual at the CDAT service. Treatment as Usual consists of planned key-working sessions every 2-4 weeks with an allocated caseworker plus monthly prescribing review appointments with a medical practitioner for patients who require drug treatment medication. Key-working sessions are primarily focused on addressing substance misuse issues using a range of intervention techniques such as motivational interviewing and brief solution-focused therapy.

Trial Locations (1)

DN1 2EZ

Aspire Drug and Alcohol Service, Doncaster

All Listed Sponsors
collaborator

University of North Carolina, Chapel Hill

OTHER

lead

University of Sheffield

OTHER

NCT03661580 - BA Trial for Co-Occurring Depression and Substance Use | Biotech Hunter | Biotech Hunter